MYCN is most frequently overexpressed in cancers of neural origin and also regulates genes functioning in ribogenesis, whereas MYCL is most often overexpressed in small cell lung carcinomas (Boon et al, 2001; Duffy et al, 2021; Tansey, 2014). This evidence concerns the gene MYCN and small cell lung carcinoma.